Latest News and Press Releases
Want to stay updated on the latest news?
-
Gala GLP-1 offers compounded tirzepatide telehealth access in all 50 states via licensed providers — no insurance required, from $179/mo.
-
2026 report on Direct Meds' compounded semaglutide and tirzepatide GLP-1 program, including pricing, telehealth process, and delivery formats.
-
Wegovy Pill vs Wegovy Shot: Daily oral vs weekly injectable semaglutide differences following 2026 FDA approval. Ro.co access pathway examined.